Judith Grau-Expósito

The paper identifies tissue-specific entry factors for SARS-CoV-2 in human tissues using single-cell analysis and functional validation.

This study evaluates the effect of combining antiretroviral therapy (ART) with TIGIT or KLRG1 blockade in humanized mice, showing improved HIV-1 suppression and delayed viral rebound.

Combining dendritic cell stimulation with anti-TIGIT antibodies enhances memory NK cell cytotoxicity against HIV-1 infected CD4+ T cells in vitro and in vivo.

This study shows that sequential IL-15 and TGF-β1 stimulation expands HIV-specific CD8+T cells with enhanced effector functions, improving HIV control during treatment interruption.